Sarah Carter | Executive Director, Head of Global Study Operations

Sarah Carter, Executive Director, Head of Global Study Operations, Amgen

Sarah Carter has more than 20 years of industry experience. She is currently the Executive Director of Global Study Operations, where she is responsible for overseeing Site and Data Management aspects of Phase 1-4 clinical studies.
She previously served as the Executive Director of Global Clinical Program Management where she led the Cardiovascular and Renal Therapeutic Area, along with the implementation of a global Functional Service Provider model for clinical trial management. Prior to this position, Sarah held several roles within Global Development Operations, from Training, Quality and Standards, to head of the Planning and Platform Services group, which included a two year focus on leading a process improvement initiative to transform the clinical trial delivery platform. Sarah also served as the Amgen representative on the TransCelerate Operating Committee.
Prior to Amgen, Sarah worked within a small CRO, responsible for project management for European Studies. Her first role within industry was as a CRA.


Clinical Trials Day 1- Monday 29th October @ 09:40

Keynote Panel Discussion- Disruptive procurement methods: choosing your CRO

  • Multiple vs singular CRO input
  • Finding the balance between expertise and ethos
  • Pros and cons of different approaches

Clinical Trials Day 1- Monday 29th October @ 14:10

The Evolution of the FSP and Risk Based Study Execution

  • How can processes evolve in an FSP model
  • How does operating in an FSP model facilitate implementation of Risk Based Study Execution?
  • Oversight of the suppliers within an FSP framework
last published: 25/Oct/18 13:45 GMT
last published: 25/Oct/18 13:45 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.


Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates